Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Stephen Oxley acquired 27 shares of Johnson Matthey stock in a transaction on Wednesday, February 19th. The shares were bought at an average cost of GBX 1,451 ($18.33) per share, with a total value of £391.77 ($494.97).
Stephen Oxley also recently made the following trade(s):
- On Wednesday, November 27th, Stephen Oxley bought 7,407 shares of Johnson Matthey stock. The stock was bought at an average price of GBX 1,343 ($16.97) per share, for a total transaction of £99,476.01 ($125,680.37).
Johnson Matthey Price Performance
Shares of JMAT opened at GBX 1,463.22 ($18.49) on Friday. The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 62.73. The stock’s 50 day moving average is GBX 1,384.37 and its two-hundred day moving average is GBX 1,479.94. Johnson Matthey PLC has a twelve month low of GBX 1,295.54 ($16.37) and a twelve month high of GBX 1,917.07 ($24.22). The firm has a market capitalization of £2.45 billion, a PE ratio of 24.86, a P/E/G ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey Cuts Dividend
The business also recently announced a dividend, which was paid on Tuesday, February 4th. Shareholders of record on Thursday, December 5th were given a dividend of GBX 22 ($0.28) per share. The ex-dividend date of this dividend was Thursday, December 5th. This represents a dividend yield of 1.47%. Johnson Matthey’s payout ratio is currently 130.84%.
Wall Street Analyst Weigh In
Several research firms have recently commented on JMAT. Berenberg Bank cut their price target on Johnson Matthey from GBX 1,650 ($20.85) to GBX 1,500 ($18.95) and set a “hold” rating for the company in a research note on Thursday, November 28th. Jefferies Financial Group restated a “buy” rating and set a GBX 1,800 ($22.74) price objective on shares of Johnson Matthey in a research report on Tuesday, December 17th.
View Our Latest Stock Report on Johnson Matthey
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Recommended Stories
- Five stocks we like better than Johnson Matthey
- What is the Hang Seng index?
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- There Are Different Types of Stock To Invest In
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- What Are Dividend Contenders? Investing in Dividend Contenders
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.